An external validation study reporting poor correlation between the claims-based index for rheumatoid arthritis severity and the disease activity score

Arthritis Research and Therapy

Volumn 17, Issue 1, 2015, Pages

  Desai, Rishi J ^a   Solomon, Daniel H ^a   Weinblatt, Michael E ^a   Shadick, Nancy ^a   Kim, Seoyoung C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

AGED; ARTICLE; CORRELATION COEFFICIENT; DAS28; DISEASE REGISTRY; DISEASE SEVERITY ASSESSMENT; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICARE; RHEUMATOID ARTHRITIS; VALIDATION STUDY; ARTHRITIS, RHEUMATOID; COHORT ANALYSIS; PROSPECTIVE STUDY; REGISTER; SEVERITY OF ILLNESS INDEX; STANDARDS; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; COHORT STUDIES; FEMALE; HUMANS; MALE; MEDICARE; PROSPECTIVE STUDIES; REGISTRIES; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84927154598     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-015-0599-0     Document Type: Article

References (14)

1. Solomon DH, Curtis JR, Saag KG, Lii J, Chen L, Harrold LR, et al. Cardiovascular risk in rheumatoid arthritis: comparing TNF-alpha blockade with nonbiologic DMARDs. Am J Med. 2013;126:730 e739-17.
2. Suissa S, Bernatsky S, Hudson M. Antirheumatic drug use and the risk of acute myocardial infarction. Arthritis Care Res. 2006;55:531-6.
3. Schneeweiss S, Solomon DH, Wang PS, Rassen J, Brookhart MA. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis. Arthritis Rheum. 2006;54:3390-8.
4. Solomon DH, Massarotti E, Garg R, Liu J, Canning C, Schneeweiss S. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA. 2011;305:2525-31.
5. Ting G, Schneeweiss S, Scranton R, Katz J, Weinblatt M, Young M, et al. Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study. Arthritis Res Ther. 2008;10:R95.
6. Kim SY, Schneeweiss S, Liu J, Daniel GW, Chang C-L, Garneau K, et al. Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Res Ther. 2010;12:R154.
7. Johnston SS, Turpcu A, Shi N, Fowler R, Chu B-C, Alexander K. Risk of infections in rheumatoid arthritis patients switching from anti-TNF agents to rituximab, abatacept, or another anti-TNF agent, a retrospective administrative claims analysis. Semin Arthritis Rheum. 2013;43:39-47.
8. Curtis JR, Xie F, Chen L, Baddley JW, Beukelman T, Saag KG, et al. The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents. Ann Rheum Dis. 2011;70:1401-6.
9. Wells G, Becker J, Teng J, Dougados M, Schiff M, Smolen J, et al. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis. 2009;68:954-60.
10. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Kerstens PJ, Nielen MM, Vos K, van Schaardenburg D, et al. DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis. Ann Rheum Dis. 2010;69:65-9.
11. Pincus T. A multidimensional health assessment questionnaire (MDHAQ) for all patients with rheumatic diseases to complete at all visits in standard clinical care. Bull NYU Hosp Jt Dis. 2007;65:150-60.
12. Sato M, Schneeweiss S, Scranton R, Katz JN, Weinblatt ME, Avorn J, et al. The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28. Arthritis Res Ther. 2006;8:R57.
13. Wolfe F, Michaud K, Simon T. Can severity be predicted by treatment variables in rheumatoid arthritis administrative data bases? J Rheumatol. 2006;33:1952-6.
14. Baser O, Du J, Xie L, Wang H, Dysinger AH, Wang L. Derivation of severity index for rheumatoid arthritis and its association with healthcare outcomes. J Med Econ. 2012;15:918-24.